trending Market Intelligence /marketintelligence/en/news-insights/trending/pe7KFXj72wsiT7-wP9AFyg2 content esgSubNav
In This List

Benitec Biopharma, NantWorks to collaborate on cancer program

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Benitec Biopharma, NantWorks to collaborate on cancer program

Benitec Biopharma Ltd. is in talks for a sub-license from Patrick Soon-Shiong's NantWorks to develop treatments for head and neck cancer using a gene silencing approach.

The company is negotiating terms of the collaboration with a targeted date for execution of Jan. 27, 2017.